MYSTAKIDOU, MD, PHD, K.; KATSOUDA, MD, E.; PARPA, BA, MA, E.; TSIATAS, MD, PHD, M. L.; VLAHOS, MD, PHD, L. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics. Journal of Opioid Management, [S. l.], v. 1, n. 1, p. 36–40, 2005. DOI: 10.5055/jom.2005.0010. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/1046. Acesso em: 28 apr. 2024.